According to a new report by Polaris Market Research, the global Non-Alcoholic Steatohepatitis (NASH) Treatment market was valued at USD 74.5 billion in 2025 and is projected to reach USD 701.66 billion by 2034, expanding at a CAGR of 28.30% over the forecast period. Growth is underpinned by rising prevalence of obesity and type 2 diabetes, expanding awareness of liver disease among...